The deal to fight the mosquito-borne virus came after lawmakers dropped a controversial provision to block payments to Planned Parenthood for women's health care.
People with tree-trunk-like legs who can't lose weight through diet and exercise may have lipedema, a lymphatic disorder. It's not clear what causes it, and most doctors aren't familiar with it.
The list of preventive services that insurers would cover without a copay could grow to include mammograms for younger women and perhaps even vasectomies for men.
It is still rare for a person struggling with alcohol abuse to be prescribed naltrexone or acamprosate, two medications that have been proven to help. Efforts are underway to change that.
The Food and Drug Administration approved a muscular dystrophy drug despite deeply flawed evidence. Was the decision a dangerous precedent or flexible pragmatism reflecting patients' values?
Harry Selker has spent his life trying to come up with better ways to keep people from dying of heart attacks. Now he's intent on figuring out if a simple, cheap medication could be a game changer.
A Swedish biologist wants to change the genes of healthy human embryos to find ways to treat infertility and other diseases. The experiments intensify ethical questions about genetic engineering.
In testimony prepared for a congressional hearing, Mylan CEO Heather Bresch says the company makes about $50 in profit on each EpiPen. Analysts say it's still a hefty margin.
Researchers were surprised that the young adults given fitness trackers lost less weight than their peers who didn't have the gizmos. Maybe they're not as motivating as we hope.